Irccs Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, 40134, Italy
Location status: Recruiting
NCT Number: NCT06918860
The investigators will collect data of patients treated surgically for impending or pathological fracture of the proximal femur due to bone metastases between 01/01/2000 and 31/12/2023 with IMN or THA or HHA or MegaTHA or Mega.
After pre-screening the databases of the respective sites, the investigators expect to find approximately a total of 600 patients. A review will be made from the medical records, radiological imaging, and histological data of partecipants.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analysis and review of imaging and clinical data
Time frame: through study completion, an average of 1 year
Assess the longevity associated with the different surgical treatments used for proximal femur bone metastases.
Time frame: At baseline ( T0)
Assess the post-operative complications associated with the different surgical treatments used for proximal femur bone metastases.
Time frame: 1 year
Assess the functional score associated with the different surgical treatments used for proximal femur bone metastases.
Contact information is provided by the study sponsor or research team.
Costantino Errani
Other
Complications, Implant Survival and Functional Results After Surgical Treatment of Bone Metastases of Proximal Femur With Intramedullary Nail or Prosthetic Reconstruction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07391410
Bone Metastases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT03261544
Bone Metastases, Neoplasms
Durham, North Carolina, United States
View Trial DetailsNCT06189079
Bone Metastases
Bologna, Emilia-Romagna, Italy
View Trial DetailsNCT03823534
Blood Protein Disorders, Bone Metastases
St Louis, Missouri, United States
View Trial Details